New Project Aims to Accelerate Adoption of Genomic Medicine in the Community Oncology Setting | GenomeWeb

By Turna Ray

While genomically guided cancer therapy has largely been limited to patients receiving treatment at academic hospitals or large research institutions, a new effort is underway to expand access to the community care setting.

Under a partnership with GE subsidiary Clarient, Accelerate Community Oncology Research Network, an organization that runs a network of oncology research sites, is laying plans to advance genomic medicine research in the community care setting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.